Hyrding develops AI-powered software that helps life sciences companies create and manage the complex regulatory documents required to bring new medical products to market. Its platform combines AI-assisted authoring, structured document control and task management within familiar Microsoft tools, allowing large teams to work on different sections of a document simultaneously while maintaining clear ownership, version control and oversight.
Ben Franklin Northeast has supported Hyrding through investment, business guidance and its location within the TechVentures technology incubator, providing the company with resources and an entrepreneurial environment as it develops and commercializes its technology.
